nodes	percent_of_prediction	percent_of_DWPC	metapath
Benzatropine—Ileus paralytic—Vincristine—sarcoma	0.0683	0.0683	CcSEcCtD
Benzatropine—Ileus—Thiotepa—sarcoma	0.0471	0.0471	CcSEcCtD
Benzatropine—Memory impairment—Thiotepa—sarcoma	0.0424	0.0424	CcSEcCtD
Benzatropine—Ileus—Vincristine—sarcoma	0.0417	0.0417	CcSEcCtD
Benzatropine—Urinary retention—Thiotepa—sarcoma	0.023	0.023	CcSEcCtD
Benzatropine—Dysphagia—Dactinomycin—sarcoma	0.0207	0.0207	CcSEcCtD
Benzatropine—Urinary retention—Vincristine—sarcoma	0.0204	0.0204	CcSEcCtD
Benzatropine—Dysuria—Thiotepa—sarcoma	0.0195	0.0195	CcSEcCtD
Benzatropine—Ileus—Epirubicin—sarcoma	0.019	0.019	CcSEcCtD
Benzatropine—Ileus—Doxorubicin—sarcoma	0.0175	0.0175	CcSEcCtD
Benzatropine—Dysuria—Vincristine—sarcoma	0.0173	0.0173	CcSEcCtD
Benzatropine—Dysphagia—Etoposide—sarcoma	0.015	0.015	CcSEcCtD
Benzatropine—Hypoaesthesia—Vincristine—sarcoma	0.0148	0.0148	CcSEcCtD
Benzatropine—Tension—Thiotepa—sarcoma	0.0143	0.0143	CcSEcCtD
Benzatropine—Nervousness—Thiotepa—sarcoma	0.0141	0.0141	CcSEcCtD
Benzatropine—Vision blurred—Thiotepa—sarcoma	0.0137	0.0137	CcSEcCtD
Benzatropine—Confusional state—Thiotepa—sarcoma	0.012	0.012	CcSEcCtD
Benzatropine—Hypoaesthesia—Etoposide—sarcoma	0.012	0.012	CcSEcCtD
Benzatropine—Vision blurred—Mitoxantrone—sarcoma	0.0119	0.0119	CcSEcCtD
Benzatropine—Tachycardia—Thiotepa—sarcoma	0.0116	0.0116	CcSEcCtD
Benzatropine—Confusional state—Mitoxantrone—sarcoma	0.0104	0.0104	CcSEcCtD
Benzatropine—Decreased appetite—Thiotepa—sarcoma	0.0103	0.0103	CcSEcCtD
Benzatropine—Decreased appetite—Dactinomycin—sarcoma	0.0103	0.0103	CcSEcCtD
Benzatropine—Constipation—Thiotepa—sarcoma	0.0102	0.0102	CcSEcCtD
Benzatropine—Tachycardia—Mitoxantrone—sarcoma	0.01	0.01	CcSEcCtD
Benzatropine—Cerebrovascular accident—Epirubicin—sarcoma	0.00994	0.00994	CcSEcCtD
Benzatropine—Feeling abnormal—Thiotepa—sarcoma	0.0098	0.0098	CcSEcCtD
Benzatropine—Feeling abnormal—Dactinomycin—sarcoma	0.00972	0.00972	CcSEcCtD
Benzatropine—Body temperature increased—Thiotepa—sarcoma	0.0094	0.0094	CcSEcCtD
Benzatropine—Body temperature increased—Dactinomycin—sarcoma	0.00933	0.00933	CcSEcCtD
Benzatropine—Cerebrovascular accident—Doxorubicin—sarcoma	0.00919	0.00919	CcSEcCtD
Benzatropine—Decreased appetite—Vincristine—sarcoma	0.00916	0.00916	CcSEcCtD
Benzatropine—Constipation—Vincristine—sarcoma	0.00901	0.00901	CcSEcCtD
Benzatropine—Decreased appetite—Mitoxantrone—sarcoma	0.00892	0.00892	CcSEcCtD
Benzatropine—Constipation—Mitoxantrone—sarcoma	0.00878	0.00878	CcSEcCtD
Benzatropine—Hypersensitivity—Thiotepa—sarcoma	0.00876	0.00876	CcSEcCtD
Benzatropine—Hypersensitivity—Dactinomycin—sarcoma	0.00869	0.00869	CcSEcCtD
Benzatropine—Confusional state—Etoposide—sarcoma	0.00861	0.00861	CcSEcCtD
Benzatropine—Feeling abnormal—Mitoxantrone—sarcoma	0.00846	0.00846	CcSEcCtD
Benzatropine—Dysphagia—Epirubicin—sarcoma	0.00842	0.00842	CcSEcCtD
Benzatropine—Tachycardia—Etoposide—sarcoma	0.00833	0.00833	CcSEcCtD
Benzatropine—Body temperature increased—Vincristine—sarcoma	0.00833	0.00833	CcSEcCtD
Benzatropine—Body temperature increased—Mitoxantrone—sarcoma	0.00811	0.00811	CcSEcCtD
Benzatropine—Dysuria—Epirubicin—sarcoma	0.00787	0.00787	CcSEcCtD
Benzatropine—Dysphagia—Doxorubicin—sarcoma	0.00779	0.00779	CcSEcCtD
Benzatropine—Hypersensitivity—Vincristine—sarcoma	0.00777	0.00777	CcSEcCtD
Benzatropine—Hypersensitivity—Mitoxantrone—sarcoma	0.00756	0.00756	CcSEcCtD
Benzatropine—Vomiting—Thiotepa—sarcoma	0.00756	0.00756	CcSEcCtD
Benzatropine—Vomiting—Dactinomycin—sarcoma	0.0075	0.0075	CcSEcCtD
Benzatropine—Rash—Thiotepa—sarcoma	0.00749	0.00749	CcSEcCtD
Benzatropine—Dermatitis—Thiotepa—sarcoma	0.00749	0.00749	CcSEcCtD
Benzatropine—Rash—Dactinomycin—sarcoma	0.00744	0.00744	CcSEcCtD
Benzatropine—Decreased appetite—Etoposide—sarcoma	0.00742	0.00742	CcSEcCtD
Benzatropine—Constipation—Etoposide—sarcoma	0.0073	0.0073	CcSEcCtD
Benzatropine—Dysuria—Doxorubicin—sarcoma	0.00728	0.00728	CcSEcCtD
Benzatropine—Nausea—Thiotepa—sarcoma	0.00706	0.00706	CcSEcCtD
Benzatropine—Feeling abnormal—Etoposide—sarcoma	0.00704	0.00704	CcSEcCtD
Benzatropine—Nausea—Dactinomycin—sarcoma	0.00701	0.00701	CcSEcCtD
Benzatropine—Body temperature increased—Etoposide—sarcoma	0.00675	0.00675	CcSEcCtD
Benzatropine—Hypoaesthesia—Epirubicin—sarcoma	0.0067	0.0067	CcSEcCtD
Benzatropine—Vomiting—Vincristine—sarcoma	0.0067	0.0067	CcSEcCtD
Benzatropine—Rash—Vincristine—sarcoma	0.00665	0.00665	CcSEcCtD
Benzatropine—Dermatitis—Vincristine—sarcoma	0.00664	0.00664	CcSEcCtD
Benzatropine—Vomiting—Mitoxantrone—sarcoma	0.00653	0.00653	CcSEcCtD
Benzatropine—Rash—Mitoxantrone—sarcoma	0.00647	0.00647	CcSEcCtD
Benzatropine—Dermatitis—Mitoxantrone—sarcoma	0.00647	0.00647	CcSEcCtD
Benzatropine—Hypersensitivity—Etoposide—sarcoma	0.00629	0.00629	CcSEcCtD
Benzatropine—Nausea—Vincristine—sarcoma	0.00626	0.00626	CcSEcCtD
Benzatropine—Hypoaesthesia—Doxorubicin—sarcoma	0.0062	0.0062	CcSEcCtD
Benzatropine—Nausea—Mitoxantrone—sarcoma	0.0061	0.0061	CcSEcCtD
Benzatropine—Tension—Epirubicin—sarcoma	0.00575	0.00575	CcSEcCtD
Benzatropine—Nervousness—Epirubicin—sarcoma	0.0057	0.0057	CcSEcCtD
Benzatropine—Vision blurred—Epirubicin—sarcoma	0.00553	0.00553	CcSEcCtD
Benzatropine—Vomiting—Etoposide—sarcoma	0.00543	0.00543	CcSEcCtD
Benzatropine—Rash—Etoposide—sarcoma	0.00538	0.00538	CcSEcCtD
Benzatropine—Dermatitis—Etoposide—sarcoma	0.00538	0.00538	CcSEcCtD
Benzatropine—Tension—Doxorubicin—sarcoma	0.00532	0.00532	CcSEcCtD
Benzatropine—Nervousness—Doxorubicin—sarcoma	0.00527	0.00527	CcSEcCtD
Benzatropine—Vision blurred—Doxorubicin—sarcoma	0.00511	0.00511	CcSEcCtD
Benzatropine—Nausea—Etoposide—sarcoma	0.00507	0.00507	CcSEcCtD
Benzatropine—Dry mouth—Epirubicin—sarcoma	0.00488	0.00488	CcSEcCtD
Benzatropine—Confusional state—Epirubicin—sarcoma	0.00483	0.00483	CcSEcCtD
Benzatropine—Tachycardia—Epirubicin—sarcoma	0.00467	0.00467	CcSEcCtD
Benzatropine—Dry mouth—Doxorubicin—sarcoma	0.00452	0.00452	CcSEcCtD
Benzatropine—Confusional state—Doxorubicin—sarcoma	0.00447	0.00447	CcSEcCtD
Benzatropine—Tachycardia—Doxorubicin—sarcoma	0.00432	0.00432	CcSEcCtD
Benzatropine—Decreased appetite—Epirubicin—sarcoma	0.00416	0.00416	CcSEcCtD
Benzatropine—Constipation—Epirubicin—sarcoma	0.00409	0.00409	CcSEcCtD
Benzatropine—Feeling abnormal—Epirubicin—sarcoma	0.00394	0.00394	CcSEcCtD
Benzatropine—Decreased appetite—Doxorubicin—sarcoma	0.00385	0.00385	CcSEcCtD
Benzatropine—Constipation—Doxorubicin—sarcoma	0.00379	0.00379	CcSEcCtD
Benzatropine—Body temperature increased—Epirubicin—sarcoma	0.00378	0.00378	CcSEcCtD
Benzatropine—Feeling abnormal—Doxorubicin—sarcoma	0.00365	0.00365	CcSEcCtD
Benzatropine—Hypersensitivity—Epirubicin—sarcoma	0.00353	0.00353	CcSEcCtD
Benzatropine—Body temperature increased—Doxorubicin—sarcoma	0.0035	0.0035	CcSEcCtD
Benzatropine—Hypersensitivity—Doxorubicin—sarcoma	0.00326	0.00326	CcSEcCtD
Benzatropine—Vomiting—Epirubicin—sarcoma	0.00304	0.00304	CcSEcCtD
Benzatropine—Rash—Epirubicin—sarcoma	0.00302	0.00302	CcSEcCtD
Benzatropine—Dermatitis—Epirubicin—sarcoma	0.00302	0.00302	CcSEcCtD
Benzatropine—Nausea—Epirubicin—sarcoma	0.00284	0.00284	CcSEcCtD
Benzatropine—Vomiting—Doxorubicin—sarcoma	0.00282	0.00282	CcSEcCtD
Benzatropine—Rash—Doxorubicin—sarcoma	0.00279	0.00279	CcSEcCtD
Benzatropine—Dermatitis—Doxorubicin—sarcoma	0.00279	0.00279	CcSEcCtD
Benzatropine—Nausea—Doxorubicin—sarcoma	0.00263	0.00263	CcSEcCtD
